Method of preventing the development of melanoma
A method for treating melanoma or preventing the development of melanoma comprising administration of a composition comprising 64 Zn e (Asp) 2 in a therapeutically effective amount. Such administration may be via injection such as intratumoral and/or intravenous injection and may be once a day or more than once a day. A composition for the treatment of or prevention of melanoma comprising 64 Zn e (Asp) 2 in a therapeutically effective amount. The composition may be a liquid suitable for injection.
1. A method of reducing melanoma tumor growth of a primary melanoma in a patient in need thereof, comprising suppressing tumor growth of the primary melanoma in said patient by administering a pharmaceutical composition comprising a therapeutically effective amount of 64 Zn e (Asp) 2 , wherein from 0.2 μg/kg patient weight/day to 2000 mg/kg patient weight/day of 64 Zn e (Asp) 2 is administered to said patient and wherein the 64 Zn e (Asp) 2 is at least 80% 64 Zn.
2. The method of claim 1 , wherein the composition is an aqueous solution.
3. The method of claim 1 , wherein 64 Zn e (Asp) 2 comprises 2 molecules of aspartic acid.
4. The method of claim 1 , wherein the composition is administered once a day.
5. The method of claim 1 , wherein the composition is administered more than once a day.
6. The method of claim 1 , wherein the composition further comprises deuterium-depleted water as a solvent.
7. The method of claim 1 , wherein the composition is administered intratumorally or intravenously to said patient.
8. The method of claim 1 , wherein the composition is administered intravenously to said patient.